Advertisement

Topics

Portola Pharmaceutical Inc. Company Profile

22:53 EDT 22nd June 2018 | BioPortfolio

Portola Pharmaceutical Inc. is a private biopahrmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics for acute and chronic cardiovascular and vascular disease

Location

270 East Grand Avenue, Suite 22
South San Fransisco
California
94080
United States of America

Contact

Phone: 650-246-7376
Email: careers@PORTOLA.COM


News Articles [349 Associated News Articles listed on BioPortfolio]

Portola Pharma CEO Bill Lis Plans to Retire from Company, Board

Portola Pharmaceuticals (NASDAQ: PTLA) CEO Bill Lis is retiring from the South San Francisco, CA, drug developer. Lis will also retire from Portola’s board of directors. The company said Lis will re...

Quotidian Technical Highlights on Selected Biotech Stocks -- Portola Pharma, Protalix ...

www.wallstequities.com/registration Portola Pharmaceuticals On Monday, shares in South San Francisco, Californiaheadquartered Portola Pharmaceuticals Inc. recorded a trading volume of 1.48 million...

Six New Drugs Get EMA Nod, Radius and Portola To Fight Rejections

Two products that the European Medicines Agency this week said should not be authorized for sale in the EU are...    

Portola's anticoagulation reversal treatment gets FDA nod

Portola Pharmaceuticals' Andexxa was approved by the FDA as an antidote for patients treated with rivaroxaban and apixaban wh -More- 

Portola investors are sick of AndexXa delays

FDA feedback indicates Portola will have to run another clinical trial for its reversal agent, likely postponing the drug's market entry even further.

FDA approves Andexxa in major boost to Portola

Shares in Portola jumped on the news, reflecting investor relief the FDA did not require additional clinical study before okaying the reversal agent.

EU Delays For Portola As CHMP Trend Votes Go Good And Bad

Portola will have to rein in its European sales ambitions as the CHMP gives early verdicts on its Factor Xa...   

FDA Gives Portola Pharma’s Andexxa a Thumbs-up

The U.S. Food and Drug Administration (FDA) approved Portola Pharmaceuticals’ Andexxa, an antidote for blood thinners rivaroxaban and apixaban.

PubMed Articles [462 Associated PubMed Articles listed on BioPortfolio]

Pharmaceutical cocrystals as an opportunity to modify drug properties: From the idea to application. A review.

The properties of many drugs which have been available on the pharmaceutical market for a long time still need to be improved. Cocrystals are the solid state drug modification which can improve such p...

Total Health-related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers.

This study aimed to examine a detailed breakdown of costs (absenteeism, presenteeism, and medical/pharmaceutical expenses), of the employees in four pharmaceutical companies in Japan.

Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs.

Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the...

Applications of various analytical techniques in quality control of pharmaceutical excipients.

Although excipients are pharmacologically inert substances, still they are integral and significant ingredients of a pharmaceutical formulation. Their amount and concentration level along with the act...

The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis.

The non-medical use (NMU) of pharmaceutical drugs is an increasing public health concern. This systematic review consolidates current knowledge about how pharmaceutical drugs are obtained for NMU and ...

Clinical Trials [300 Associated Clinical Trials listed on BioPortfolio]

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Individualized Pharmaceutical-care in Outpatients With Cancer Pain

The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients

Companies [1034 Associated Companies listed on BioPortfolio]

Portola Pharmaceutical Inc.

Portola Pharmaceutical Inc. is a private biopahrmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics for acute and chronic cardiovascular and vascular...

Merck and Portola Pharmaceuticals

Portola Pharmaceuticals discovers and develops innovative therapeutics based on targets with established proof of concept that are designed to provide significant advances over cu...

Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals develops innovative therapeutics based on targets with established proofs of concept that are designed to provide significant advances over current treatments for cardiovascula...

Biogen Idec and Portola Pharmaceuticals

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market therapies for serious diseases with a focus on neurology, immunology and hemophilia. Founded in ...

Pharmaceutical Online

Pharmaceutical Online, the pharmaceutical manufacturing industry’s leading Web site. Our online community serves the product-sourcing and information-seeking needs of pharmaceutical professionals wo...

More Information about "Portola Pharmaceutical Inc." on BioPortfolio

We have published hundreds of Portola Pharmaceutical Inc. news stories on BioPortfolio along with dozens of Portola Pharmaceutical Inc. Clinical Trials and PubMed Articles about Portola Pharmaceutical Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Portola Pharmaceutical Inc. Companies in our database. You can also find out about relevant Portola Pharmaceutical Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...


Corporate Database Quicklinks



Searches Linking to this Company Record